Your browser doesn't support javascript.
loading
Cas9-Cleavage Sequences in Size-Reduced Plasmids Enhance Nonviral Genome Targeting of CARs in Primary Human T Cells.
Jing, Ruirui; Jiao, Peng; Chen, Jiangqing; Meng, Xianhui; Wu, Xiaoyan; Duan, Yanting; Shang, Kai; Qian, Liling; Huang, Yanjie; Liu, Junwei; Huang, Tao; Jin, Jin; Chen, Wei; Zeng, Xun; Yin, Weiwei; Gao, Xiaofei; Zhou, Chun; Sadelain, Michel; Sun, Jie.
Afiliación
  • Jing R; Department of Cell Biology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Jiao P; Institute of Hematology, Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, 310058, China.
  • Chen J; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, 310058, China.
  • Meng X; Department of Cell Biology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Wu X; Institute of Hematology, Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, 310058, China.
  • Duan Y; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, 310058, China.
  • Shang K; Department of Cell Biology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Qian L; Institute of Hematology, Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, 310058, China.
  • Huang Y; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, 310058, China.
  • Liu J; Department of Cell Biology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Huang T; Institute of Hematology, Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, 310058, China.
  • Jin J; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, 310058, China.
  • Chen W; Department of Cell Biology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Zeng X; Institute of Hematology, Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, 310058, China.
  • Yin W; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, 310058, China.
  • Gao X; Department of Cell Biology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Zhou C; Institute of Hematology, Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, 310058, China.
  • Sadelain M; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, 310058, China.
  • Sun J; Department of Cell Biology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
Small Methods ; 5(7): e2100071, 2021 07.
Article en En | MEDLINE | ID: mdl-34927998

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plásmidos / Linfocitos T / Inmunoterapia Adoptiva / Sistemas CRISPR-Cas Límite: Animals / Humans Idioma: En Revista: Small Methods Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plásmidos / Linfocitos T / Inmunoterapia Adoptiva / Sistemas CRISPR-Cas Límite: Animals / Humans Idioma: En Revista: Small Methods Año: 2021 Tipo del documento: Article País de afiliación: China